Trading Summary - December 19. More significant progress

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
178
Trading Summary - December 19.

More significant progress today for $EVSV - with hopefully those relatively new to the stock realizing that they need to hit the ask to get in - and / or bid realistically - as just a few buys of 5K > 10K will move the stock up another .2 increment.

The ideal time to hit the ask is when manipulators / bashers trying to hold the stock back - either out of spite or because they believe nonsense posts on iHub will dupe people into trading on the bid - try putting a walked down ask below a previous hod seen recently.

At the open, the fake undercut walked down asks were still at .3200 and .3800 - below the .4000 hod seen on the last run.

A few test buys were done by new interest - just because the ask doesn't count down does not mean the MMs are not playing straight. Some of the bashers have already admitted they are using AON orders - which are not visible and they can be filling first.

New visible bidders in depth came in at .2500 above the previous .2315 - at .2800 above the previous .2700 - and I made my extant top bid at .3000 visible and was joined by at least one other trader.

Bidders were warned that only one person was likely to be able to buy small amounts at .3200 and one at .3800 - the rest would be paying .4000+.

This then transpired to be the case.

After one buy of 3,000 at .3200 - the rest of the fake balance was cancelled.

When the .3800 undercut ask was hit, only 657 shares were filled - the fake balance was cancelled - and the ask went straight to .5000.

When the bashers came round from the shock - and other former bidders failed to hit the ask to keep the momentum going (we could easily have got to .6000 or .7000 if around 20,000 shares had been bought) - the manipulators tried juggling around with undercut asks.

First was .4800 - quickly cancelled and retreating to .4980.

Then there were further attempts at .4975, 4500 and finally a ludicrous .3300.

In the meantime a new bidder came in at .3100 but did not get a fill at that unrealistic level.

I did post that bids would need to be .4500 to be realistic - and if someone had done that they might have got a fill from the person that put .4500 on the ask.

On December 17 I wrote "The next buyer of 100K should see .6000 or .7000 up - and the next 2 after that 1.000+."

Those estimates can probably be halved now - 50K to get .7000 up and a further 100K to get 1.000.

Hod was .4980 - with 2,000 shares bought there.

If anyone is stupid enough to leave any of the undercut asks up tomorrow - particularly under .4000 - they can expect to lose them and not be allowed back in as the whale longs in this will outbid them at any price that makes sense in the their overall inventory of shares.

Overall, 7,148 shares were bought today - getting a move from .3200 > .4980 - with no shares sold under the successive hods - .3200 open > .3800 > .4980.

The main target remains $1 > $2 range - as has been predicted consistently ever since the highly successful r/s with 24 hours notice in January 2019.

Items below the line unchanged since the last long-version Trading Summary:

Top traders of $EVSV have now each earned close to $6-figures on it in the last 3 years and multiple $5-figures already in 2019 - most of which is since the successful r/s 11 months ago - due to multiple surges and the thin share structure for a stock in this price range.

The latest DD / Rolling Brief - updated December 15, 2019 - is here:

https://investorshangout.com/post/view?id=5619482

Key Points from recent PRs (not including December 17 PR) are here:

https://investorshangout.com/post/view?id=5619497

The Share Structure was last updated on November 29, 2019 - showing no significant change from the previous update.

The 2019 Q3 was filed on November 18, 2019 in a timely manner.

The 2019 Q2 was filed on August 7, 2019 in a timely manner and gave a very good description of the holding company $EVSV's current portfolio and partnerships (unable to copy - read in filing).

Trading on December 17 illustrated yet again just how difficult it is to accumulate an inventory of 100K > 150K of $EVSV - like the top traders in it have - to be ready for the move to $1+ - within even a .2000 price band increment.

The next buyer of 100K (50K now ?) should see .6000 or .7000 up - and the next 2 (100K ?) after that 1.000+.

The top traders in $EVSV aren't going to waste out time nickel and diming trying to fill on the bid [/b]when there is so much else going on with Watch List stocks to attend to daily. We will just take out everything on the ask under 1.000 at a time of our choosing.

Top traders who are the movers and shakers of $EVSV will continue the transfer of more of their profits from other trades into $EVSV up until the first hemp crop revenues come out.

The usual moving around of the insignificant undercut asks by the iHub scammers of course has no effect and they are currently being allowed to continue to post to themselves on iHub completely oblivious to the fact that all traders of significance are networking by other means on telegram and slack.

The modus operandi of the iHub scammers hasn't changed for 11 months since they failed to buy at .0001 on the day before the successful r/s: post blatant nonsense on iHub + attempt to support their fake narrative by trading at or below the visible bid price (often with orders placed before the open + then not pay attention to actual other trading that follows + attempt to walk a small ask down to artificially low levels + not realize that their manipulation attempts don't affect the views of the 160+ social media OTC influencers who have $EVSV on their radar now.

All these manipulation attempts enable top traders on low commission rates - who don't have to worry about partial fills - to just keep accumulating cheap shares almost daily.

As I have warned before, the scammers who attempt paint downs on thin stocks are likely to find themselves detected by their brokers compliance department and reported to the SEC. This is what will then happen:

https://www.sec.gov/news/press-release/2019-216

I'll be mainly #boycottiHub - I have now alerted the more influential / serious Penny Stock Geeks and relevant Whale Team rooms on telegram and slack.

In addition of course we have 160+ traders / analysts / alerters on social media that have $EVSV on their radar to start scaling in and / or jumping on board "just-in-time".

Reminder - Tax Loss Disallowed ! You will incur a "wash sale" and have a tax loss disallowed if you:

- Sell any shares that had a purchase cost basis higher than any shares you have bought in the last 30 days.

or

- Buy shares at any price within 30 days of those that you sold for a tax loss.

Warning ! Anyone who is seen posting nonsense on iHub on any on the thinly traded stocks I'm a shareholder in - especially when small paint downs are also seen along with undercut asks - can expect to have their user ID passed to the SEC which has now started to take action against those using the exact modus operandi I have detected and commented on for the past 2 years:

https://www.sec.gov/news/press-release/2019-216




Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

WeightWatchers Shifts 2025 Earnings Call for Key Accounting Updates

Updated Category News Views 154

WeightWatchers Adjusts Schedule for 2025 Earnings Report WW International, Inc. (NASDAQ: WW), widely recognized for its innovative weight management solutions, has made an important change regarding its upcoming earnings report. The company has rescheduled its earnings release and associated conference call originally intended for August 5, 2025. This Rescheduling is...

Continue Reading
Investors Alert: Key Investigations into Regeneron Pharmaceuticals

Updated Category News Views 120

Investors Take Note: Faruqi & Faruqi Seeks to Help Faruqi & Faruqi, LLP, a prominent national securities litigation firm, is leading an investigation focusing on investors who may have sustained significant losses with Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). The firm encourages those who believe they have suffered losses of over $100,000 due to the company’s...

Continue Reading
Waller's Bold Critique of Powell: A Call for Rate Cuts

Updated Category News Views 233

Waller’s Challenge to Economic Caution Federal Reserve Governor Christopher Waller has made headlines by challenging the stance of Chairman Jerome Powell, particularly regarding his assertion that economic data is too sparse to draw clear conclusions. Waller believes the Fed should proceed with easing monetary policy, even amidst perceived gaps in information. Ending...

Continue Reading
Michael John Politis Recognized as Elite Attorney in America

Updated Category News Views 276

Michael John Politis Achieves National Recognition Michael John Politis, a distinguished attorney at Politis & Matovina, P.A., has garnered significant acclaim by being recognized as a member of the Nation's Top One Percent. This prestigious acknowledgment is bestowed by the National Association of Distinguished Counsel (NADC). The NADC is committed to upholding the...

Continue Reading
Home Buying Opportunities: Navigating the Market's Shift

Updated Category News Views 74

Introduction For many home buyers, fall typically signals a slow down in the housing market. But this year, things might unfold differently. With mortgage rates dropping and inventory on the rise, buyers could have a chance to find their dream homes during what is usually seen as the offseason. Affordability Improves The recent decline in monthly mortgage payments has...

Continue Reading